Fusaroli M.; Giunchi V.; Battini V.; Puligheddu S.; Khouri C.; Carnovale C.; Raschi E.; Poluzzi E., Enhancing Transparency in Defining Studied Drugs: The Open-Source Living DiAna Dictionary for Standardizing Drug Names in the FAERS, «DRUG SAFETY», 2024, 47, pp. 271 - 284 [articolo]Open Access
Sisi, Monia; Vitale, Giovanni; Fusaroli, Michele; Riefolo, Mattia; Giunchi, Valentina; D’Errico, Antonietta; Ardizzoni, Andrea; Raschi, Emanuel; Gelsomino, Francesco, Capmatinib-Induced Liver Injury as Emerging Toxicity of MET Inhibitors in Patients With NSCLC Pretreated With Immune Checkpoint Inhibitors, «JTO CLINICAL AND RESEARCH REPORTS», 2023, 4, Article number: 100563, pp. 1 - 8 [articolo]
Giunchi, Valentina; Fusaroli, Michele; Hauben, Manfred; Raschi, Emanuel; Poluzzi, Elisabetta, Challenges and Opportunities in Accessing and Analysing FAERS Data: A Call Towards a Collaborative Approach, «DRUG SAFETY», 2023, 46, pp. 921 - 926 [articolo]
Fusaroli M.; Pelletti G.; Giunchi V.; Pugliese C.; Bartolucci M.; Necibi E.N.; Raschi E.; De Ponti F.; Pelotti S.; Poluzzi E., Deliberate Self-Poisoning: Real-Time Characterization of Suicidal Habits and Toxidromes in the Food and Drug Administration Adverse Event Reporting System, «DRUG SAFETY», 2023, 46, pp. 283 - 295 [articolo]Open Access
Fusaroli M.; Giunchi V.; Battini V.; Gringeri M.; Rimondini R.; Menchetti M.; Radice S.; Pozzi M.; Nobile M.; Clementi E.; De Ponti F.; Carnovale C.; Raschi E.; Poluzzi E., Exploring the underlying mechanisms of drug-induced impulse control disorders: a pharmacovigilance-pharmacodynamic study, «PSYCHIATRY AND CLINICAL NEUROSCIENCES», 2023, 77, pp. 160 - 167 [articolo]Open Access
Valentina Giunchi, L’impatto ambientale dei farmaci sulle acque superficiali e la sua stima attraverso i dati di utilizzo, «RECENTI PROGRESSI IN MEDICINA», 2023, 114, pp. 372 - 374 [articolo]
Giunchi V.; Fusaroli M.; Linder E.; Villén J.; Wettermark B.; Nekoro M.; Raschi E.; Lunghi C.; Poluzzi E., The environmental impact of pharmaceuticals in Italy: Integrating healthcare and eco-toxicological data to assess and potentially mitigate their diffusion to water supplies, «BRITISH JOURNAL OF CLINICAL PHARMACOLOGY», 2023, 89, pp. 2020 - 2027 [articolo]Open Access
Raschi E.; Fusaroli M.; Giunchi V.; Repaci A.; Pelusi C.; Mollica V.; Massari F.; Ardizzoni A.; Poluzzi E.; Pagotto U.; Di Dalmazi G., Adrenal Insufficiency with Anticancer Tyrosine Kinase Inhibitors Targeting Vascular Endothelial Growth Factor Receptor: Analysis of the FDA Adverse Event Reporting System, «CANCERS», 2022, 14, Article number: 4610, pp. 1 - 13 [articolo]Open Access
Fusaroli M.; Raschi E.; Giunchi V.; Menchetti M.; Rimondini Giorgini R.; De Ponti F.; Poluzzi E., Impulse Control Disorders by Dopamine Partial Agonists: A Pharmacovigilance-Pharmacodynamic Assessment Through the FDA Adverse Event Reporting System, «INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY», 2022, 25, pp. 727 - 736 [articolo]Open Access
Giunchi, V; Fusaroli, M; Lunghi, C; Zongo, A; Raschi, E; Poluzzi, E, Post-marketing safety profile of cannabis products: Signals from the FDA adverse event reporting system, «PHARMACOEPIDEMIOLOGY AND DRUG SAFETY», 2022, 31, pp. 222 - 223 [abstract]
Lunghi C.; Trevisan C.; Fusaroli M.; Giunchi V.; Raschi E.; Sangiorgi E.; Domenicali M.; Volpato S.; De Ponti F.; Poluzzi E., Strategies and Tools for Supporting the Appropriateness of Drug Use in Older People, «PHARMACEUTICALS», 2022, 15, Article number: 977, pp. 1 - 15 [articolo]Open Access
Lunghi, C; Fusaroli, M; Giunchi, V; Raschi, E; Zongo, A; Poluzzi, E, What Is the Safety Profile of Cannabis-Based Medications? Analysis of the Post-Marketing Signals from the FDA Adverse Event Reporting System, «DRUG SAFETY», 2022, 45, pp. 1242 - 1243 [abstract]
